Understanding processes in the development and manufacture of biological drug substances is crucial to successfully navigating the clinical phases towards commercial launch, all within ever‑tightening time constraints, and regulatory frameworks.
Claudia Berdugo-Davis
Advertisement
Claudia Berdugo-Davis, PhD, is director of Process Development, Catalent Biologics.
Articles by Claudia Berdugo-Davis
Advertisement
Latest Updated Articles
Streamlining and Standardizing Process CharacterizationPublished: May 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
